BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 27034277)

  • 1. Insulin Signaling and Heart Failure.
    Riehle C; Abel ED
    Circ Res; 2016 Apr; 118(7):1151-69. PubMed ID: 27034277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin signaling in the heart.
    Abel ED
    Am J Physiol Endocrinol Metab; 2021 Jul; 321(1):E130-E145. PubMed ID: 34056923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation and dysregulation of glucose transport in cardiomyocytes.
    Montessuit C; Lerch R
    Biochim Biophys Acta; 2013 Apr; 1833(4):848-56. PubMed ID: 22967513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular-cellular effects of insulin and possible mechanisms of insulin resistance development in patients with ischemic heart disease (CAD)].
    Telkova IL
    Usp Fiziol Nauk; 2005; 36(2):55-65. PubMed ID: 15909664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.
    Zhang L; Jaswal JS; Ussher JR; Sankaralingam S; Wagg C; Zaugg M; Lopaschuk GD
    Circ Heart Fail; 2013 Sep; 6(5):1039-48. PubMed ID: 23861485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct Evidence that Myocardial Insulin Resistance following Myocardial Ischemia Contributes to Post-Ischemic Heart Failure.
    Fu F; Zhao K; Li J; Xu J; Zhang Y; Liu C; Yang W; Gao C; Li J; Zhang H; Li Y; Cui Q; Wang H; Tao L; Wang J; Quon MJ; Gao F
    Sci Rep; 2015 Dec; 5():17927. PubMed ID: 26659007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure.
    Chokshi A; Drosatos K; Cheema FH; Ji R; Khawaja T; Yu S; Kato T; Khan R; Takayama H; Knöll R; Milting H; Chung CS; Jorde U; Naka Y; Mancini DM; Goldberg IJ; Schulze PC
    Circulation; 2012 Jun; 125(23):2844-53. PubMed ID: 22586279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
    Hong EG; Jung DY; Ko HJ; Zhang Z; Ma Z; Jun JY; Kim JH; Sumner AD; Vary TC; Gardner TW; Bronson SK; Kim JK
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1687-96. PubMed ID: 17911348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial compartmentalization of signal transduction in insulin action.
    Baumann CA; Saltiel AR
    Bioessays; 2001 Mar; 23(3):215-22. PubMed ID: 11223878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes Alters the Expression and Translocation of the Insulin-Sensitive Glucose Transporters 4 and 8 in the Atria.
    Maria Z; Campolo AR; Lacombe VA
    PLoS One; 2015; 10(12):e0146033. PubMed ID: 26720696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial infarction in rats causes partial impairment in insulin response associated with reduced fatty acid oxidation and mitochondrial gene expression.
    Amorim PA; Nguyen TD; Shingu Y; Schwarzer M; Mohr FW; Schrepper A; Doenst T
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1160-7. PubMed ID: 20850803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial contractile dysfunction is associated with impaired mitochondrial function and dynamics in type 2 diabetic but not in obese patients.
    Montaigne D; Marechal X; Coisne A; Debry N; Modine T; Fayad G; Potelle C; El Arid JM; Mouton S; Sebti Y; Duez H; Preau S; Remy-Jouet I; Zerimech F; Koussa M; Richard V; Neviere R; Edme JL; Lefebvre P; Staels B
    Circulation; 2014 Aug; 130(7):554-64. PubMed ID: 24928681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial insulin resistance, metabolic stress and autophagy in diabetes.
    Mellor KM; Bell JR; Ritchie RH; Delbridge LM
    Clin Exp Pharmacol Physiol; 2013 Jan; 40(1):56-61. PubMed ID: 22804725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sweet heart - contributions of metabolism in the development of heart failure in diabetes mellitus.
    Stratmann B; Tschoepe D
    Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S40-5. PubMed ID: 18777453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diet-induced obesity obstructs insulin signaling in the heart.
    Young LH
    Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H306-7. PubMed ID: 19940075
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular implications of insulin resistance and non-insulin-dependent diabetes mellitus.
    McNulty PH; Ettinger SM; Gilchrist IC; Kozak M; Chambers CE
    J Cardiothorac Vasc Anesth; 2001 Dec; 15(6):768-77. PubMed ID: 11748532
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin resistance: metabolic mechanisms and consequences in the heart.
    Abel ED; O'Shea KM; Ramasamy R
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2068-76. PubMed ID: 22895668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin signaling regulates cardiac titin properties in heart development and diabetic cardiomyopathy.
    Krüger M; Babicz K; von Frieling-Salewsky M; Linke WA
    J Mol Cell Cardiol; 2010 May; 48(5):910-6. PubMed ID: 20184888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear receptor agonists improve insulin responsiveness in cultured cardiomyocytes through enhanced signaling and preserved cytoskeletal architecture.
    Montessuit C; Papageorgiou I; Lerch R
    Endocrinology; 2008 Mar; 149(3):1064-74. PubMed ID: 18063688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.